Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
mean decrease » a decrease (Expand Search)
-
341
-
342
-
343
-
344
-
345
-
346
-
347
-
348
-
349
-
350
Evaluation index results for the JS-10 phantom.
Published 2025“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
-
351
NEMA IEC body phantom.
Published 2025“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
-
352
Relationship between contrast, noise, and CNR.
Published 2025“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
-
353
JS-10 phantom.
Published 2025“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
-
354
The raw data used for the analyses in this study.
Published 2025“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …”
-
355
-
356
-
357
-
358
Data_Sheet_1_Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy.pdf
Published 2020“…</p><p>Conclusion: Compared to a standard prostate planning, applying dose constraints to a patient-specific SRR by using the achievable mean dose model decreased the mean dose by 7.7 Gy to the SRR and may decrease the relative risk of RB by 22%.…”
-
359
-
360
FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc.
Published 2019“…<p>(A) Immunoblotting for the activated form of AKT–phospho-AKT (Ser473)–and total AKT revealed a decrease in phospho-AKT with no accompanying change in total AKT, indicating a decrease in AKT signaling with FTY720 treatment. …”